Trial intelligence / Profile preview

Remimazolam vs propofol for postoperative sleep quality in elderly major abdominal surgery

ChiCTR2300076964Phase 4Not yet recruiting

Sponsor
Peking University First Hospital
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in Postoperative sleep disturbance (PSD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Total duration of sleep on the first night after surgery. Planned start Oct 2023; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

Postoperative sleep disturbance (PSD)

Beyond the preview

Go deeper on ChiCTR2300076964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call